Pear Therapeutics, Inc.

Big Health announced on 8 August it has received US Food and Drug Administration clearance for its digital therapeutic (DTx), SleepioRx, for treating chronic insomnia as an adjunct to usual care for

Listen to the podcast below: Open Media Medtronic Report Finds Latest Tech Absent From Most ORs A recent report from device maker Medtronic plc offers good news and bad news for surgeons and patie

Click Therapeutics, Inc. ’s acquisition of Better Therapeutics, Inc. ’s AspyreRx – the first FDA-authorized prescription digital therapeutic (PDT) for type-2 diabetes – among other assets, reflects t

FDA Seeks Industry Representative For GMP Committee The FDA needs a new industry voice for its quality systems advisory panel, the agency said in a 5 April Federal Register Announcement. The notice ma